Beginnings
In NASA's test laboratories, the effects of weightlessness on the human body have been investigated in cooperation with the German Space Agency (DLR) for more than 30 years.
During the past years, the research focused on the aetiology of space sickness, the regulation of arterial pressure and the efficacy of a "Lower Body Negative Pressure Device" in supporting cardiovascular functions.
During the past years, the research focused on the aetiology of space sickness, the regulation of arterial pressure and the efficacy of a "Lower Body Negative Pressure Device" in supporting cardiovascular functions.
Research was undertaken both at the earth-based NASA laboratories on earth and in orbit during numerous missions.
Usage
Over a period of many years, NASA developed and enhanced the LBNPD technology. The reduced muscular activity in weightless space markedly impairs physical performance under gravity. Prolonged stays in a weightless environment without measures to preserve the physical capabilities of the astronauts were a safety risk. The usage of LBNPD technology significantly reduced this safety risk.
NASA Space Test in 1973
Future
The importance of LBNPD technology will increase in the future, because long research trips to the International Space Station (ISS) are planned. The old dream of mankind to travel to Mars could also soon become true and the starting point could be the new space station. The six-month-long outward journey could be managed without significant negative impact on the physical performance of the astronauts thanks to LBNPD. Without LBNPD, even the low level of gravity on Mars would greatly impair the astronauts' ability to move about because of their prolonged exposure to weightlessness during the flight.
Efficacy
The significant benefits of LBNPD technology are being increasingly recognised by the medical community. The WEYERGANS High-Care AG was among the first companies to pick up NASA's research results and, based on these, to develop a highly effective method of treatment for leg disorders and vascular diseases.
The central element of this method is the Vacumed. A device that displays its origins in NASA's space technology by means of its advanced design.
Optimised for the patented intermittent application of pressure and negative pressure, this high-tech device, a space research spin-off, is available for prevention and therapy of patients.
The central element of this method is the Vacumed. A device that displays its origins in NASA's space technology by means of its advanced design.
Optimised for the patented intermittent application of pressure and negative pressure, this high-tech device, a space research spin-off, is available for prevention and therapy of patients.
